Provision of Aseptic Manufacturing Services, including chemotherapy and Related Supply Services for ADHB

Details

Tender Closed
RFx ID :	22087830
Tender Name :	Provision of Aseptic Manufacturing Services, including chemotherapy and Related Supply Services for ADHB
Reference # :	P19-376 (A)
Open Date :	Friday, 13 December 2019 2:00 PM (Pacific/Auckland UTC+13:00)
Close Date  :	Monday, 17 February 2020 4:00 PM (Pacific/Auckland UTC+13:00)
Tender Type :	Request for Proposals (RFP)
Tender Coverage :	Sole Agency  [?]
Categories :	85000000 - Healthcare Services
Regions:	Auckland
Exemption Reason :	None
Required Pre-qualifications :	None
Contact :	Alberto Areias alberto.areias@healthsourcenz.co.nz 0212413610
Alternate Physical Delivery Address  :
Alternate Physical Fax Number  :
Agency Address :	NEW ZEALAND

With the opportunity to reassess its services and together with information gathered in the recently released Expression of Interest P19-376 for potential strategic partnerships for the Aseptic production unit, ADHB now seeks proposals around the following options:
a. Outsource all, or part, of its production to a strategic partner (range of products will be agreed and there will be exceptions), or
b. Enter into a strategic partnership with a supplier to operate, and potentially build, an aseptic production facility and provide these services on ADHBs behalf. Options have been detailed further in the RFP.

An independent probity auditor has been appointed by HealthSource and ADHB to overview the RFP process, verify that procurement documentation is complied with, and that probity principles are adhered to. The Probity Auditor is not a member of the evaluation team.
The Probity Auditor will:
•provide independent, high-level opinion and advice to HealthSource and ADHB on the probity of the procurement processes and management of probity and conflicts of interest; and
•audit this procurement processes and report to HealthSource, ADHB and its stakeholders on the procurement process regarding compliance with the Government’s Principles and Rules of Sourcing, best practice regarding probity, and their subsequent evaluation processes.

The Probity Auditor’s name and contact details are as follows:
Mr. Bill Inglis
Principal
McHale Group Ltd
DDI: +64 4 496 5583
Mobile: +64 27 555 7909
Email: bill.inglis@mchalegroup.co.nz
The Probity Auditor is not an employee of HealthSource or ADHB. Any Respondent concerned about any probity issue with the RFP or subsequent procurement process has the right to contact the Probity Auditor and request his review. The outcome will be documented with copies to the Respondent who raised the issue and healthSource ADHB.

This tender has been awarded.

• Slade Health Pty Ltd - 11-13, Palmer Court, Mt Waverley, Victoria, 3149, AUSTRALIA

Further Award Information:
Notification re RFP (P19-376A) - Request for Proposal (RFP) for the provision of Aseptic Manufacturing Services including Chemotherapy and Related Supply Services. Auckland District Health Board (ADHB) has awarded the compounding requirements to Slade Health New Zealand Limited. The estimated commencement of the new services will be Q4 of 2022.

Award Date: Sunday, 1 January 2023 (Pacific/Auckland UTC+13:00)
Date RFx was completed/updated: Monday, 28 March 2022 10:46 AM (Pacific/Auckland UTC+13:00)